Philips (NYSE: PHG) announced today that it received FDA 510(k) clearance for its SmartHeart planning solution.
The orthopedic firm published data showing patients with its Persona IQ implant had lower revision and physical therapy rates than those who received traditional knee implants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results